LianBio Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
LianBio quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2023.
  • LianBio Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$24M, a 9.78% decline year-over-year.
  • LianBio Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$88M, a 22.3% increase year-over-year.
  • LianBio annual Net Income (Loss) Attributable to Parent for 2022 was -$110M, a 43.8% increase from 2021.
  • LianBio annual Net Income (Loss) Attributable to Parent for 2021 was -$196M, a 40.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$88M -$24M -$2.14M -9.78% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$85.8M -$21.6M +$20.8M +49% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$107M -$24M +$3.68M +13.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-13
Q4 2022 -$110M -$18.3M +$2.92M +13.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$113M -$21.9M -$8.79M -67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$104M -$42.4M +$58M +57.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$162M -$27.7M +$33.8M +55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$196M -$21.2M -$8.46M -66.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$188M -$13.1M +$107M +89.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$295M -$100M -$97.9M -3895% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$197M -$61.6M -$57.5M -1396% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$140M -$12.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$120M Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-01-10
Q2 2020 -$2.51M Apr 1, 2020 Jun 30, 2020 10-Q/A 2022-01-10
Q1 2020 -$4.11M Jan 1, 2020 Mar 31, 2020 10-Q/A 2022-01-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.